DOI: 10.11958/20212207
The clinical efficacy and safety of anlotinib and albumin-bound paclitaxel as the third-line therapy in patients with non-small cell lung cancer
ZHAO Zilong
ZHANG Meiyun
GAO Hui
DU Wei
BA Yaer
LYU Yihua
Machine-generated Keywords：
Publication Date：2022-05-15
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：5( 539-543 )